News about Biomedical Advanced Research and Development Authority. Commentary and archival information about Biomedical Advanced Research and Development Authority from The New York Times.

SANTA MONICA, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and ...

--BioVaxys Technology Corp. is pleased to announce that it has been invited to and joined The Rapid Response Partnership Vehicle, a consortium of large and small biopharma, contractors, government ...

The Biomedical Advanced Research and Development Authority (BARDA) has granted Moderna a $176 million project award under the Rapid Response Partnership Vehicle (RRPV) Consortium, with the goal of ...

CHELMSFORD, Mass., Oct. 27, 2020 /PRNewswire/ -- First Light Diagnostics, Inc., a developer of breakthrough automated products for the rapid diagnosis and treatment of life-threatening infections ...

--SCYNEXIS, Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today applauded action taken this week by the ...

Biomedical_Advanced_Research_and_Development_Authority. Biomedical_Advanced_Research_and_Development_Authority. Skip to main content. Open Main Menu Navigation. Open Search.

Morningstar brands and products Company Portfolio ...

Biomedical Advanced Research and Development Authority (BARDA) M2D2. ... and attacks, pandemic influenza, and emerging infectious diseases. Specifically, BARDA supports the advanced development and ...

San Diego, CA, October 1, 2013 - Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has ...

BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY Array ( [results] => Array ( [0] => Array ( [ArticleID] => 670625 [Title] => Amid Japan crisis, hunt for better ...